Roche shares fall after poster highlights effects of obesity drug
The poster, released as part of this week’s European Association for the Study of Diabetes annual meeting, showed side effects including nausea, vomiting and diarrhoea for Roche’s injectable drug, CT-388
Mon, 09 Sep, 2024